Popular Keywords

Allergy

Cosmetic Dermatology

Cryosurgery

Dermatopathology

Hair Transplantation

Immunodermatology

A Split Face Comparative Study of Melasma Treatment with Fractional Erbium: Glass 1540 Nanometer and Nd: YAG Q-Switched 1064 Nanometer Laser Systems

Correspondence to Author:  Kazar Jadi Baluki1, 

Laser Research Unit, College of Medicine, University of Kufa, Iraq.

Abstract:

Background:   chloasma may be a common skin disorder associate degreed optical device began to be an possibility of treatment. Objective: to check between the effectiveness of Erbium: Glass 1540 nm optical device and Nd: YAG Q-Switched 1064nm optical device within the treatment of chloasma. Methods: This comparative split face clinical study was meted out in optical device analysis Unit, school of medication, University of Kufa, Iraq; for the amount from October 2012 to December 2013. every patient’s face was divided into 2 halves, every [*fr1] was treated with one among the 2 optical device devices employed in this study; third Erbium: Glass 1540nm and Nd: YAG Q-Switched 1064nm lasers. The severity of chloasma was assessed before, once treatment and three months later with the changed chloasma space and Severity Index (MASI) Score and by images. Results: The mean changed MASI scores were reduced within the facial halves treated by Erbium: Glass 1540nm optical device (statistically extremely important P worth of zero.001) quite those treated by Nd: YAG Q-Switched 1064nm optical device (statistically important P worth of zero.022). Conclusion: The treatment was well tolerated and patients incontestable positive responses with promising results.

Keywords:
Melasma, Erbium, Glass laser, Nd, YAG Q-Switched laser.

Citation:

Kazar Jadi Baluki1. A Split Face Comparative Study of Melasma Treatment with Fractional Erbium: Glass 1540 Nanometer and Nd: YAG Q-Switched 1064 Nanometer Laser Systems. Annals of Dermatological Science 2024.

Journal Info

  • Journal Name: Annals of Dermatological Science
  • Impact Factor: 1.7
  • ISSN: 2831-8129
  • DOI: 10.52338/Aods
  • Short Name: AODS
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility